These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6273619)

  • 1. [Normal pyrimidine 5'-nucleotidase activity level of Japanese subjects and a significance as a marker for low concentration of lead in blood (author's transl)].
    Sato Y; Sasaki T; Taniguchi N; Saito K
    Nihon Eiseigaku Zasshi; 1981 Jun; 36(2):518-25. PubMed ID: 6273619
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
    Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
    S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) and concentration of magnesium or zinc in blood in workers exposed to lead].
    Ichiba M; Tomokuni K
    Sangyo Igaku; 1988 Sep; 30(5):408-9. PubMed ID: 2849695
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of erythrocyte pyrimidine 5'-nucleotidase activity in the detection and early diagnosis of lead poisoning. A comparison with zinc-protoporphyrin].
    Brunet M; Vives Corrons JL; Torra M; Rodamilans M; Pujades A; Corbella J; Pascual A
    Med Clin (Barc); 1988 Oct; 91(14):521-4. PubMed ID: 2851079
    [No Abstract]   [Full Text] [Related]  

  • 5. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
    Rocco RM; Smart JL; Brown DR; Blumberg JB
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the usefulness of erythrocyte enzymes in exposure to low levels of lead].
    Lembas-Bogaczyk J; Rzepka Z; Mach U; Latkowski T
    Przegl Lek; 1983; 40(6):533-5. PubMed ID: 6314440
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro effect of heavy metals on the activity of pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in the human erythrocyte (author's transl)].
    Tomokuni K; Ogata M
    Sangyo Igaku; 1980 Jul; 22(4):282-3. PubMed ID: 6259388
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between lead concentration in blood and the activities of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinate dehydratase in the mice exposed to lead.
    Tomokuni K; Ogata M
    Arch Toxicol; 1981 Mar; 47(1):67-9. PubMed ID: 6269517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium.
    Mohammed-Brahim B; Buchet JP; Lauwerys R
    Int Arch Occup Environ Health; 1985; 55(3):247-52. PubMed ID: 2987134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
    Cook LR; Angle CR; Stohs SJ
    Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in workers exposed to lead.
    Ichiba M; Tomokuni K
    Br J Ind Med; 1988 Oct; 45(10):718-9. PubMed ID: 2848571
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on 5'-nucleotidase. I. An automated micromethod based on the coupled enzymatic reactions and the serum activities in healthy subjects (author's transl)].
    Okuda M; Kamikura Y; Suzuki H; Makino T
    Rinsho Byori; 1981 Dec; 29(12):1282-6. PubMed ID: 6279938
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
    Cook LR; Angle CR; Kubitschek CE; Stohs SJ
    J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides.
    Paglia DE; Valentine WN; Fink K
    J Clin Invest; 1977 Dec; 60(6):1362-6. PubMed ID: 915002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte pyrimidine 5'-nucleotidase test for occupational lead exposure.
    Ichiba M; Tomokuni K; Sugimoto K
    Ind Health; 1987; 25(4):195-203. PubMed ID: 2828288
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyrimidine-specific 5' nucleotidase activity in bovine erythrocytes: effect of phlebotomy and lead poisoning.
    George JW; Duncan JR
    Am J Vet Res; 1982 Jan; 43(1):17-20. PubMed ID: 6283951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The infraclinical diagnosis of lead poisoning (author's transl)].
    Fendler JP; Dongradi G; Buc HA
    Ann Med Interne (Paris); 1978; 129(8-9):473-80. PubMed ID: 717995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.
    Sakai T; Araki T; Ushio K
    Br J Ind Med; 1988 Jun; 45(6):420-5. PubMed ID: 2840110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low-level lead exposure on pyrimidine 5'-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5'-nucleotidase in the pathogenesis of lead-induced anemia.
    Paglia DE; Valentine WN; Dahlgren JG
    J Clin Invest; 1975 Nov; 56(5):1164-9. PubMed ID: 1184742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.